Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery

ConditionsChest Wall Tumor Reconstruction Surgery

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-80

SponsorWu Weiming

About this trial

Chest wall tumors should be completely resection as much as possible while malignant chest wall tumors should be extensively resection. If not completely resection, it will recur in the short time and affect the patient's survival. At present, the surgical resection range mainly relies on preoperative imaging examination and the experience of the surgeon. It lacks precise guidance. This can easily lead to incomplete resection. In addition, the reconstruction materials required for reconstruct the excised chest wall defection are often generated in a standardized manner, lacking intraoperative adjustability. To address this clinical issue, we plan to carry out the research on the application of artificial Intelligence (AI) assisted chest wall tumor resection combined with personalized 3D preformed chest wall defection reconstruction system in chest wall tumor surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18-70 years old, male or female not limited

Anesthesia ASA score I-II

Malignant tumor of soft tissue in the chest

Malignant tumors of ribs, rib cartilage, and sternum

Disqualifiers

Patients with distant metastasis detected during preoperative examination

Inoperable tumor

During the examination, it was discovered that the patient had another type of malignant tumor present

ECOG 4

Trial design

Design model

Single group

Treatments tested in this trial

Chest wall tumor resection by the artificial intelgent assistent
Device
we plan to carry out of the research on the application of artificial intelligence (AI) assisted chest wall tumor research combined with a personalized 3D preformed chest wall defect reconstruction system in chest wall tumor surgery. Data will be imported into a computer to draw a 3D model of the tumor and construct an ideal resection range to ensuring sufficient surgical margins while avoiding damage to important nerve and vascular tissues in the chest. Preformed titanium plates will be prepared based on the calculated resection range and the titanium plates will be detachable assembly components through screws, which can be adjusted at any time according to the surgical situation.

Treatment groups

50 Participants

are divided into 1 treatment group

Group A: chest wall tumorExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

the tumor status of surgical margin

Visible tumor residue with naked eye, tumor cells visible under microscope, no tumor cells observed under microscope

Time frame

3 year

Secondary outcomes

Stability after chest wall reconstruction

3D pre formed titanium plates are used for chest wall defect reconstruction. Based on the size and shape of the defect during surgery, suitable titanium plates are selected and fixed with nooses for chest wall defect reconstruction surgery.

Time frame

3 year

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Wu Weiming

Lead sponsor

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: